Table 3

Estimate of disability-adjusted life-years gained by Helicobacter pylori screening and treatment in different populations*

PopulationMean DALYs gained95% CI
Global8 814 6495 742 067 to 11 887 230
Men5 650 5603 672 479 to 7 628 640
Women3 165 0332 049 244 to 4 280 822
East Asia3 754 8262 459 850 to 5 049 802
South Asia1 211 289786 289 to 1 636 290
North Africa and the Middle East395 681254 071 to 537 291
Eastern Europe468 015304 225 to 631 804
Western Europe470 721303 803 to 637 640
High income North America192 702124 729 to 260 675
Central Latin America224 425144 883 to 303 966
Southern Latin America93 39159 901 to 126 881
Australasia18 28611 638 to 24 933
  • *These analyses relate to all of the impact of H. pylori testing and eradication in the population described, and the DALYs gained is what would be achieved hypothetically over the lifetime of the population being screened at a given time point.

  • DALYs, disability-adjusted life-years; H. pylori, Helicobacter pylori.